Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees: Guidance for Industry - FDA Guidance Document

Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees: Guidance for Industry - FDA Guidance Document | Global Key Solutions